Pfizer
Indian govt set to ban 1,200 fixed-dose combination drugs, reports
March 18, 2016Business Services, Medical Communications, Sales and Marketing Abbott Laboratories, Pfizer, cough drug, pharma
Indian regulators are set to ban an additional 1,200 fixed-dose combinations, sent for probe by Drug Controller General of India …
FDA approves Breckenridge’s generic of Pfizer’s anti-epilepsy drug
March 18, 2016Research and Development, Sales and Marketing FDA, Neurontin, Pfizer, anti-epilepsy, approval, breckenridge, gabapentin, tris pharma
Breckenridge Pharmaceutical Inc. has announced that their generic of Pfizer’s anti-epilepsy drug Neurontin (gabapentin) has been approved by the US …
Teva says closing buy of Allergan’s generics biz may take longer
March 16, 2016Business Services, Research and Development, Sales and Marketing Allergan, M&A, MA, Pfizer, Teva
Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA) said its $40.5 billion acquisition of Allergan’s generics business will take longer than expected, …
UPDATE: Pfizer gets interim stay on cough syrup ban
March 15, 2016Manufacturing and Production, Research and Development Abbott Laboratories, Corex, Pfizer, Pfizer India
Shares in Pfizer India continued to tumble for a second day even as an Indian court granted the company a …
FDA approves Pfizer sNDA for Xalkori
March 14, 2016Research and Development, Sales and Marketing Cancer, EMA, NSCLC, Pfizer, Xalkori (crizotinib)
The US FDA has approved Pfizer’s supplemental new drug application (sNDA) for its kinase inhibitor Xalkori in treating patients with …
MSF challenges Pfizer’s pneumonia vaccine patent in India
March 11, 2016Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine
The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …
FDA grants approval for first generic version of Viagra
March 10, 2016Manufacturing and Production, Research and Development, Sales and Marketing FDA, Pfizer, Teva, erectile dysfunction, generic, viagra
The US Food and Drug Administration (FDA) has granted approval to the first generic version of Pfizer’s blockbuster erectile dysfunction …
Pfizer enters $5 billion share buyback deal with Goldman Sachs
March 9, 2016Business Services, Research and Development Pfizer, Share buyback, Stock, markets
US drug major Pfizer (NYSE: PFE) on Wednesday said it has entered into an accelerated share repurchase agreement with Goldman, …
Late-stage Pfizer drug study shows significant reduction in haemophilia B bleeding
March 9, 2016Research and Development BeneFIX, Pfizer, haemophilia B
Pfizer on Wednesday said late-stage trials for its drug candidate to treat haemophilia B showed prophylactic use resulted in significant reduction …
Delivering successful new drugs
March 1, 2016Manufacturing and Production, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, patents, pharma
Pharma companies are struggling with challenges specific to their industry. Patents for many drugs, that had created massive amounts of …
ViiV completes BMS HIV pipeline purchase
February 23, 2016Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, GSK, HIV, Pfizer, Shionogi, ViiV
ViiV Healthcare has completed its previously-announced acquisition of Bristol-Myers Squibb’s late-stage HIV R&D assets and its portfolio of preclinical and …
Pfizer pays $784m to settle Protonix overcharge claims
February 17, 2016Research and Development, Sales and Marketing Medicaid, Pfizer, Wyeth, protonix
US drugs giant Pfizer is to pay more than $784 million to settle claims that it overcharged health insurer Medicaid …
Biosimilars: Can the US catch up in 2016?
February 12, 2016Medical Communications, Sales and Marketing Eli Lilly, Enbrel, FDA, Neulasta, Novartis, Pfizer, Sandoz, Zarxio, biosimilars
What are biosimilars? Biosimilars are essentially the biological equivalent of generic drugs to their branded small-molecule counterparts (what Ibuprofen is …
FDA advisory committee recommends approval of Remicade biosimilar
February 10, 2016Research and Development, Sales and Marketing FDA, Pfizer, Remicade, biosimilar, celltrion
An FDA advisory panel yesterday voted overwhelmingly in favour of approving CT-P13- Celltrion’s biosimilar version of Johnson&Johnson’s blockbuster arthritis drug …
New breast cancer initiative brings together pharma and Europe’s top researchers
February 9, 2016Medical Communications, Research and Development Pfizer, breast cancer
The UK charity Breast Cancer Now (BCN) has announced a new initiative seeking to bring together Europe’s top researchers and …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
